SCHEMBL9572986

SCHEMBL9572986

CCC(CCOC=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.40
LMNA P02545 3/20 0.37
CYP2D6 P10635 4/20 0.36
TAAR1 Q96RJ0 2/20 0.36
HTT P42858 1/20 0.36
CYP1A2 P05177 2/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
KMT2A Q03164 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
CHRM5 P08912 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9572675 0.90 CHRM2 (0.39) CCR5LMNACYP2D6TAAR1HTT
SCHEMBL9572901 0.88 AOC3 (0.36) CCR5LMNACYP2D6HTTCYP1A2
SCHEMBL7232754 0.82 CCR5 (0.41) CCR5LMNACYP2D6TAAR1HTT
SCHEMBL5859438 0.80 HRH1 (0.45) LMNACYP2D6TAAR1HTTCYP1A2
SCHEMBL9572888 0.79 RIPK1 (0.47) TAAR1ALDH1A1
SCHEMBL16352603 0.78 LMNA (0.42) CCR5LMNACYP2D6TAAR1HTT
SCHEMBL6013632 0.77 CCR5 (0.42) CCR5LMNACYP2D6TAAR1CYP1A2
SCHEMBL9572741 0.76 SMN1; SMN2 (0.39) CCR5LMNACYP2D6HTTCYP1A2
SCHEMBL1834382 0.76 CYP1A2 (0.46) LMNACYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL1834387 0.76 CYP1A2 (0.46) LMNACYP2D6CYP1A2PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 EP disclosed
US-5011938-A Antimicrobials ELI LILLY AND COMPANY (US) 1991-04-30 US disclosed
US-4940718-A BACTERICIDES ELI LILLY AND COMPANY (US) 1990-07-10 US disclosed
US-4902707-A Bicyclic pyrazolidinones, compositions and use ELI LILLY AND COMPANY (US) 1990-02-20 US disclosed
US-4826992-A MICROBIOCIDE INTERMEDIATES ELI LILLY AND COMPANY (US) 1989-05-02 US disclosed
EP-0310214-A2 7-Substituted bicyclic pyrazolidinones ELI LILLY AND COMPANY (US) 1989-04-05 EP disclosed
US-4795815-A BACTERICIDES, MICROBIOCIDES ELI LILLY AND COMPANY (US) 1989-01-03 US disclosed
US-4716232-A 1-(vinyl phosphonate adduct) pyrazolidinones ELI LILLY AND COMPANY (US) 1987-12-29 US disclosed
EP-0203722-A1 Bicyclic pyrazolidinones ELI LILLY AND COMPANY (US) 1986-12-03 EP disclosed
EP-0203723-A1 2,3-(dihydro)bicyclic pyrazolidinones ELI LILLY AND COMPANY (US) 1986-12-03 EP disclosed
EP-0202794-A1 7-Substituted-2,3-(Dihydro) bicyclic pyrazolidinones ELI LILLY AND COMPANY (US) 1986-11-26 EP disclosed
EP-0202046-A1 7-Substituted bicyclic pyrazolidinones ELI LILLY AND COMPANY (US) 1986-11-20 EP disclosed